Drug profile · INN
ifosfamide
HOLOXAN
ifosfamide (HOLOXAN) is a dna inhibitor. Associated with BAXTER HEALTHCARE PTY LTD. Route of administration: injection. Current US regulatory status: approved.
Drug details — ifosfamide
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 1
- Programs
- 18
- Data quality
- 0.89
Quick answer
ifosfamide (HOLOXAN) is a dna inhibitor. Associated with BAXTER HEALTHCARE PTY LTD. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is ifosfamide?
ifosfamide (HOLOXAN) is a dna inhibitor. Associated with BAXTER HEALTHCARE PTY LTD. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ifosfamide?
HOLOXAN is a marketed brand name for ifosfamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ifosfamide?
ifosfamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.